Company Filing History:
1 out of 1,217 
1 out of 832,966 Years Active: 1990-1996
Title: The Innovations of Gabriel Bialy
Introduction
Gabriel Bialy is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with estrogenic and androgenic activities. With a total of 2 patents, Bialy's work has the potential to impact various therapeutic applications.
Latest Patents
Bialy's latest patents include "Orally active derivatives of 1,3,5(10)-estratriene" and "Long-acting androgenic compounds and pharmaceutical compositions thereof." The first patent presents 17.beta.-nitro and 11.beta., 17.beta.-dinitro esters of estradiol, which are synthesized from 3-acyloxy-17-keto- or 3,17-dihydroxy-1,3,5-estratrienes. These compounds exhibit estrogenic activity, which could be beneficial in various medical treatments. The second patent focuses on long-acting androgenic compositions that comprise C.sub.4 -C.sub.6 cycloalkyl carboxylic acids of testosterone, combined with a pharmaceutically acceptable carrier medium. This innovation allows the ester to be dissolved in an acceptable oily medium or suspended in an aqueous medium in the form of micronized or milled particles.
Career Highlights
Throughout his career, Bialy has worked with the United States of America as represented by the Department of Health. His contributions to the field have been recognized for their potential to advance medical science and improve patient outcomes.
Collaborations
Bialy has collaborated with notable individuals such as Hyun K Kim and Richard P Blye. These partnerships have likely enhanced the scope and impact of his research and innovations.
Conclusion
Gabriel Bialy is a distinguished inventor whose work in pharmaceutical innovations demonstrates the importance of research in developing new therapeutic compounds. His patents reflect a commitment to advancing medical science and improving health outcomes.